Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience.

MLA

Parra-Izquierdo, Viviana, et al. “Tofacitinib in the Treatment of Moderate to Severe Ulcerative Colitis in Colombia: Real World Experience.” Gastroenterologia y Hepatologia, vol. 46, no. 7, Aug. 2023, pp. 512–21. EBSCOhost, https://doi.org/10.1016/j.gastrohep.2022.10.020.

APA

Parra-Izquierdo, V., Frías-Ordoñez, J. S., Márquez, J. R., Juliao-Baños, F., Galindo, P., Cuadros, C., Rojas, C., Rojas, N., Ardila, O., Tovar-Fierro, G., García-Duperly, R., Vargas, M., & Flórez-Sarmiento, C. (2023). Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience. Gastroenterologia y Hepatologia, 46(7), 512–521. https://doi.org/10.1016/j.gastrohep.2022.10.020

Chicago

Parra-Izquierdo, Viviana, Juan Sebastián Frías-Ordoñez, Juan Ricardo Márquez, Fabián Juliao-Baños, Pablo Galindo, Carlos Cuadros, Carlos Rojas, et al. 2023. “Tofacitinib in the Treatment of Moderate to Severe Ulcerative Colitis in Colombia: Real World Experience.” Gastroenterologia y Hepatologia 46 (7): 512–21. doi:10.1016/j.gastrohep.2022.10.020.